07.01.2015 • NewsBioethanolBiofuelsBP

Shell JV in Brazil Invests Heavily in Ethanol

Raízen, a joint venture of oil and petrochemicals group Shell with Brazil's Cosan, will spend nearly $1 billion on building eight second generation bioethanol plants for the production of ethanol from sugarcane waste.

A recently completed plant built by the jv, Brazil's largest ethanol producer, has capacity to produce 40 million liters. Plans are to increase output by as much as 50% up to 2024, João Alberto Abreu, the company's agroindustrial director, told the London-based Financial Times newspaper.

With the completion of eight plants, Shell JV will be able to produce roughly 1 billion liters of biofuel annually.

While production of cellulosic ethanol is still more expensive than conventional ethanol, Abreu told the newspaper he expects costs to fall as the enzymes needed in the production process become more widely available.

Many ethanol producers are said to be struggling to stay afloat following decades of research and failed attempts. In 2012, BP scrapped plans for a $300 million cellulosic ethanol plant in Florida, but other companies, such as DuPont, have taken up the challenge.

In Brazil, Abreu said he believes domestic ethanol demand will continue rising, with export opportunities to Europe.

With crude oil prices tumbling 30% since June, analysts say Shell's upstream petrochemical business has seen its profit margins come under pressure and may soon be labeled by analysts as an underperforming asset.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.